arrow
H

Helen Yu

Gilead Sciences, Inc.
H指数:25
被引数:3,905

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Discovery of Lenacapavir: First-in-Class Twice-Yearly Capsid Inhibitor for HIV-1 Treatment and Pre-exposure Prophylaxis

Lenacapavir的发现:首个每半年给药一次的衣壳抑制剂,用于HIV-1治疗和暴露前预防

2025-10-010
OAAI
Activating PKC-ε induces HIV expression with improved tolerability
2025-02-060
OAAI
Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability

具有改善的代谢稳定性的非肽模拟HIV蛋白酶抑制剂的临床前表征

2024-04-031
OAAI
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro
2023-02-2325
OAAI
Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis B
2020-05-1458
PREAI
Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune Diseases
2020-02-1232
OAAI
A highly potent long-acting small-molecule HIV-1 capsid inhibitor with efficacy in a humanized mouse model
2019-09-09105
OAAI
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance Profile
2016-12-01253
OAAI
A Subset of Latency-Reversing Agents Expose HIV-Infected Resting CD4+ T-Cells to Recognition by Cytotoxic T-Lymphocytes
2016-04-15178
OAAI